Open AccessBufalin attenuates triple‑negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
Author(s) -
Fei Chen,
Li Zhu,
Junyan Hu,
Shujun Jiang,
Hui Liu,
Jie Zheng,
Jiandong Wang,
Feng Wang,
Zhe Li
Publication year - 2020
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2020.12028
Subject(s) - sox2 , triple negative breast cancer , cancer research , bufalin , cell cycle , oncogene , cancer stem cell , cancer , cell growth , stem cell , homeobox protein nanog , breast cancer , biology , medicine , apoptosis , transcription factor , induced pluripotent stem cell , microbiology and biotechnology , embryonic stem cell , biochemistry , genetics , gene